If you or a loved one has COVID-19, here’s what to consider before seeking experimental treatments.
By JoNel Aleccia, Kaiser Health News
The U.S. government announced this week that it had an agreement with Gilead Sciences to make the bulk of their production of remdesivir available to Americans for the next three months.
By Maria Cheng, Associated Press, Marilynn Marchione, AP Chief Medical Writer
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.